Analysis
Introductory vs renewal pricing: the GLP-1 trap
Many GLP-1 programs advertise a low first-month price that renews substantially higher. The introductory rate is a customer-acquisition tool, not the
Many GLP-1 programs advertise a low first-month price that renews substantially higher. The introductory rate is a customer-acquisition tool, not the price you'll pay month after month. Always find the recurring rate before committing, because that's the number that governs your bill.
The full picture
A $99 'first month' can renew at $200+ once the introductory discount lapses. For a one-month trial that's fine; for a treatment that trials show is usually long-term, the recurring price is what matters. The gap between intro and renewal is where budgets get blown.
This is why effective-monthly comparison beats headline shopping. A program with a flat, transparent renewal rate can be cheaper over a year than one with a shock-low first month and a steep renewal — even if the flat program looks pricier on day one.
The tell is disclosure. A trustworthy program shows the recurring price prominently; a manipulative one buries it. If you have to hunt for the renewal rate, treat that as information about the company.
Effective monthly cost falls with term — microdose semaglutide (NexLife) — same medication, lower per-month cost on longer commitment
Frequently asked questions
Why is my GLP-1 price higher after the first month?
The first month was likely an introductory rate; the renewal is the real recurring price.
How do I avoid the trap?
Find the recurring rate before signing up and compare on effective monthly cost.
Related: evidence database · cost calculator · semaglutide · tirzepatide.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.